SCHEMBL10201173

SCHEMBL10201173

CC(C)(C)OC(=O)N1[C@@H]2CC2C[C@H]1c1nc2ccc(C#Cc3ccc(-c4cnc([C@@H]5C[C@H]6C[C@H]6N5C(=O)OC(C)(C)C)[nH]4)cc3)cc2[nH]1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGDS O60760 3/20 0.36
SSTR3 P32745 1/20 0.35
CHEK2 O96017 6/20 0.35
GABRA1 P14867 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA3 P34903 1/20 0.33
GABRA2 P47869 1/20 0.33
HCRTR1 O43613 5/20 0.33
HCRTR2 O43614 5/20 0.33
BACE1 P56817 1/20 0.33
CYP2C9 P11712 2/20 0.32
KCNH2 Q12809 2/20 0.32
TBK1 Q9UHD2 1/20 0.32
NR1I2 O75469 1/20 0.32
ABCB11 O95342 1/20 0.32
CYP3A4 P08684 1/20 0.32
OPRK1 P41145 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13221409 1.00 HPGDS (0.36) HPGDSSSTR3CHEK2GABRA1GABRG2
SCHEMBL12406068 0.91 HPGDS (0.39) HPGDSSSTR3CHEK2BACE1CYP2C9
SCHEMBL13221411 0.89 GPR119 (0.34) HPGDSCHEK2GABRA1GABRG2GABRB3
SCHEMBL10201175 0.89 GPR119 (0.34) HPGDSCHEK2GABRA1GABRG2GABRB3
SCHEMBL882833 0.89 HPGDS (0.34) HPGDSSSTR3GABRA1GABRG2GABRB3
SCHEMBL10201179 0.88 HPGDS (0.34) HPGDSSSTR3GABRA1GABRG2GABRB3
SCHEMBL13221410 0.88 HPGDS (0.34) HPGDSSSTR3GABRA1GABRG2GABRB3
SCHEMBL12295798 0.85 HPGDS (0.40) HPGDSSSTR3GABRA1GABRG2GABRB3
SCHEMBL1293217 0.84 HPGDS (0.37) HPGDSSSTR3CHEK2TBK1
SCHEMBL1293215 0.84 HPGDS (0.37) HPGDSSSTR3CHEK2TBK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2601188-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-10-18 EP disclosed
WO-2012018325-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-02-09 WO disclosed